Nadeem Moiz believes in building a trusted, customer-centric company that leads in science-driven aesthetics, therapeutics and consumer skincare under one brand. He aims to shape the next era of beauty with innovation grounded in authenticity and strong partnerships with providers and patients.

Revance’s offerings include DAXXIFY, the first U.S.-manufactured peptide-formulated neuromodulator for moderate to severe frown lines; SkinPen microneedling device; and RHA dynamic movement dermal fillers. Consumer skincare brands PanOxyl, Blue Lizard and StriVectin address concerns from acne to anti-aging.

Early-stage commercialization of DAXXIFY provides an opportunity to drive revenue growth by expanding the sales force, enhancing provider and patient education, and increasing market penetration. The unified structure across divisions supports scalable rollout and deeper industry impact.